| Literature DB >> 28725921 |
Rüdiger Lange1, Frank Erbguth2.
Abstract
Due to the increasing life expectancy and a higher incidence in the elderly, the number of elderly patients with idiopathic Parkinson's disease will increase in the coming years. Since the burden of comorbidities is higher and medication side effects are more likely in the elderly, particularly in the light of frequently occurring polypharmacy, increased awareness and therapeutic knowledge is necessary. Besides the therapy of motor symptoms, non-motor symptoms, e. g. neuropsychiatric and autonomic disorders, also need to be addressed as they can also greatly impair the quality of life. In more advanced stages of the disease, non-pharmacological treatment, medical aids and caregiving become more important. A close integration in the social environment is of great importance for the implementation.Entities:
Keywords: Aged; Levodopa; Mobility; Parkinson Disease; Polypharmacy
Mesh:
Substances:
Year: 2017 PMID: 28725921 DOI: 10.1007/s00391-017-1284-5
Source DB: PubMed Journal: Z Gerontol Geriatr ISSN: 0948-6704 Impact factor: 1.281